Table 1 Clinical characteristics of the 158 NSCLC patients.
From: The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
Characteristics | Number | Results | p-value | ||
|---|---|---|---|---|---|
Positive | Negative | Â | |||
Age (years) | 156 | Â | Â | 0.2002 | |
 <60 | 105 | 82 | 23 |  | |
 >60 | 53 | 35 | 18 |  | |
Gender | 158 | Â | Â | 0.5075 | |
 Male | 78 | 53 | 27 |  | |
 Female | 78 | 47 | 31 |  | |
Adenocarcinoma stage | 135 | Â | Â | 0.0947 | |
 Poorly | 41 | 23 | 18 |  | |
 Moderately | 51 | 30 | 21 |  | |
 advanced | 43 | 33 | 10 |  | |
TNM stage | 156 | Â | Â | 0.0059** | |
 I | 42 | 15 | 27 |  | |
 II | 40 | 12 | 28 |  | |
 III | 34 | 15 | 19 |  | |
 IV | 40 | 26 | 14 |  | |
Distant metastasis | 149 | Â | Â | 1.001 | |
 Yes | 39 | 26 | 13 |  | |
 No | 110 | 72 | 38 |  | |
Chemotherapy | 64 | Â | Â | 1.000 | |
 Yes | 16 | 9 | 7 |  | |
 No | 48 | 26 | 22 |  | |